Skip to content
On March 15, Amarin (NASDAQ:AMRN) announced that it was suspending all field-based face-to-face interactions until March 30. While it will continue to monitor the situation, it's likely that the March 30 deadline will come and go, extending well into April. A lengthy pause on the sale of its cardiovascular drug Vascepa could be detrimental to Amarin stock.Source: Pavel Kapysh / Shutterstock.com "As a company focused for more than a decade on fighting cardiovascular disease, which in the United States alone results in one stroke, heart attack or death every 14 seconds, we are determined to do our part to protect public health and the health of our many valued employees," said John Thero, CEO of Amarin. Of course, over the long haul, the coronavirus has provided investors with an opportunity to buy Amarin at a price that hasn't been seen since September 2018. If you've got the risk tolerance to ride...
Unfortunately for some shareholders, the Exxon Mobil (NYSE:XOM) share price has dived 43% in the last thirty days......
To the annoyance of some shareholders, WW International (NASDAQ:WW) shares are down a considerable 60% in the last......
Cannabis is an early-stage business and early stage businesses often must raise capital. Tilray (NASDAQ: TLRY) stock is no exception. But the timing and circumstances surrounding a stock offering can tell an investor a lot about a company.Source: Jarretera / Shutterstock.com Tilray recently opted to raise $90 million via a stock offering. Unfortunately, the timing and details of the offering may be a huge red flag for investors. The OfferingOn Friday, Mar. 13, Tilray announced it had priced a $90 million stock offering at $4.75. TLRY stock subsequently tanked and for good reason. There are plenty of things for investors to hate about this offering.InvestorPlace - Stock Market News, Stock Advice & Trading TipsFirst, let's start with the price. The $4.75 price represented a 30.3% discount to Thursday's closing price of $5.95. Offerings are almost always priced below market price as an incentive for investors to buy in, but a 30%...
Potential W. P. Carey Inc. (NYSE:WPC) shareholders may wish to note that the MD & Head of Investments, Gino Sabatini......
Those following along with Simon Property Group, Inc. (NYSE:SPG) will no doubt be intrigued by the recent purchase of......
